NEW YORK, Aug. 21 - Cepheid today said it has won a $376,000 grant from the US National Institutes of Health to co-develop a diagnostic test for Mycobacetria tuberculosis.
The project, a collaboration with the University of Medicine and Dentistry of New Jersey, calls for Cepheid to use its GeneXpert platform to develop test protocols, procedures, and reagents.
Click here for more information.